中文
Selected Investments

Shanghai Han Yu Medical Technology Co., Ltd. is focused on the development of mitral valve interventional medical devices company. Its core product is ValveClamp, which is a mitral valve involved in the domestic research and development of animal experiments.
NewMed Medical Co., Ltd. is a high-tech medical enterprise which was established in March 2015 and located in Shanghai Medical valley PLUS, Zhoupu Town, Pudong District, Shanghai.
Qingyun Medical (brand name Zhi Yun Yi Lu) focuses on digital marketing of pharmaceuticals in hospital channels. Qingyun offers customized multi-channel marketing solutions for pharmaceutical companies with its social customer management system integrating Wechat channels, digital sales representatives, web conferences and online forums.
Alpha Biopharma is supported by the domestic and foreign famous funds, and committed to the clinical development of global innovator drug.

Chipscreen  is a leading integrated biotech company specialized in discovery and development of novel small molecule pharmaceuticals. 

Neurelis is a neuroscience-based specialty pharmaceutical company providing innovative approaches to target unmet medical needs. Our approach combines novel technologies designed to enhance therapeutic benefit and address gaps in patient care.

Fountain Medical Development Ltd. (FMD) is a privately owned contract research organization (CRO) headquartered in Beijing, China. As a leading full-service clinical CRO in China and East Asia, FMD offers a full range of ICH-GCP compliant clinical research services for domestic and multinational clients conducting clinical research in China and Asia.

Tianjin Cinorch Pharmaceutical Co., Ltd., has established in Mar. 2000 with a registered capital of USD 9,799,000 and an aggregate investment of USD 20,490,400, is a Sino-foreign joint venture co-built by Tianjin Zhongxin Pharmaceutical Group Corporation Ltd., Tianjin Kangchen Ruixin Pharmaceutical Group Co., Ltd. and Luxemburg Orchid Limited.

Bringspring (300290) is a technology listed company established in 2005. Driven by ongoing innovative, focus on health data and intelligent cloud services areas.

Founded in 1997, Cathay Biotech Co. is the first and only industrial biotechnology company that has realized commercial-scale production of revolutionary bio-technologies including long chain dibasic acids (LCDA), biobutanol, and bio-based bio-based DN5 (1,5-pentanediamine). 

Wuhan Hiteck Biological Pharma Co., Ltd Founded in 2000, Wuhan Hiteck has become a leading bio-pharmaceutical company in China. Its leading product, the Mouse Nerve Growth Factor for Injection is a first-in-class drug. Other pipeline products include frozen anti-HBV transfer factor injection powder and thrombin, as well as chemicals products.

Shaanxi Kanghui Pharmaceutical Co., LTD. is a pharmaceutical high-tech enterprise integrating pharmaceutical research, development, production and sales.

Nuokang Biopharma has a diverse portfolio of products focused on the hematological and cardiovascular markets in China. Its leading flagship product Baquting is the premium hemocoagulase brand with No. 1 market share, prescribed in over 2,400 hospitals in China.

BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market.